Silk Road Medical Overview
- Year Founded
-
2007
- Status
-
Acquired/Merged
- Employees
-
474
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$1.13B
Silk Road Medical General Information
Description
Silk Road Medical Inc is a medical device company focused on reducing the risk of stroke and its devastating impact. The company has a new approach for the treatment of carotid artery disease called transcarotid artery revascularization, or TCAR, which it seeks to establish as the standard of care. TCAR relies on two novel concepts - minimally-invasive direct carotid access in the neck and high-rate blood flow reversal during the procedure to protect the brain - and combines novel endovascular techniques with fundamental surgical principles. TCAR using its portfolio of products has been clinically demonstrated to reduce the upfront morbidity and mortality risks commonly associated with carotid endarterectomy. The company generates all of its revenue in the United States.
Contact Information
Website
www.silkroadmed.com(Operating Subsidiary)
Corporate Office
- 1213 Innsbruck Drive
- Sunnyvale, CA 94089
- United States
Corporate Office
- 1213 Innsbruck Drive
- Sunnyvale, CA 94089
- United States
Silk Road Medical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 15. Merger/Acquisition | 17-Sep-2024 | $1.13B | Completed | Generating Revenue | ||
| 14. 2PO | 20-Oct-2022 | Completed | Generating Revenue | |||
| 13. Debt Refinancing | 01-Jun-2022 | Completed | Generating Revenue | |||
| 12. Secondary Transaction - Open Market | 12-Aug-2019 | Completed | Generating Revenue | |||
| 11. IPO | 04-Apr-2019 | Completed | Generating Revenue | |||
| 10. Debt - General | 01-Oct-2018 | Completed | Generating Revenue | |||
| 9. Later Stage VC (Series C) | 07-Jul-2017 | Completed | Generating Revenue | |||
| 8. Later Stage VC (Series C) | 20-Oct-2015 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series C) | 13-Aug-2014 | $15M | $61.1M | Completed | Startup | |
| 6. Later Stage VC (Series B) | 08-May-2013 | $17M | $46.1M | Completed | Startup |
Silk Road Medical Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series B | ||||||||
| Series A1 | 3,000,000 | $0.001000 | $0.1 | $1.25 | $1.25 | 1x | $1.25 | 4.42% |
| Series A | 4,400,000 | $0.001000 | $0.08 | $1 | $1 | 1x | $1 | 6.48% |
Silk Road Medical Comparisons
Industry
Financing
Details
Silk Road Medical Competitors (28)
One of Silk Road Medical’s 28 competitors is ShockWave Medical, a Formerly VC-backed company based in Santa Clara, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| ShockWave Medical | Formerly VC-backed | Santa Clara, CA | ||||
| Penumbra | Formerly VC-backed | Alameda, CA | ||||
| Spine Wave | Venture Capital-Backed | Shelton, CT | ||||
| Evasc | Formerly VC-backed | Vancouver, Canada | ||||
| Medtronic | Corporation | Minneapolis, MN |
Silk Road Medical Patents
Silk Road Medical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20250144395-A1 | Systems and methods for transfemoral carotid intervention | Pending | 03-Nov-2023 | ||
| WO-2025096742-A1 | Systems and methods for transfemoral carotid intervention | Inactive | 03-Nov-2023 | ||
| WO-2025019858-A1 | Flow control mechanism for neuroprotection system | Inactive | 20-Jul-2023 | ||
| WO-2025019858-A9 | Flow control mechanism for neuroprotection system | Inactive | 20-Jul-2023 | ||
| US-20260096882-A1 | Large bore sheath device including coupling device | Pending | 30-Sep-2022 | A61F2/2436 |
Silk Road Medical Signals
Silk Road Medical Former Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| CRG | Lender/Debt Provider | Minority | ||
| Janus Henderson Investors | Asset Manager | Minority | ||
| Norwest | Venture Capital | Minority | ||
| The Vertical Group | Venture Capital | Minority | ||
| Warburg Pincus | PE/Buyout | Minority |
Silk Road Medical ESG
Risk Overview
Risk Rating
Updated April, 30, 2025
24.57 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 14,766
Rank
Percentile
Healthcare
Industry
of 581
Rank
Percentile
Medical Devices
Subindustry
of 199
Rank
Percentile
Silk Road Medical FAQs
-
When was Silk Road Medical founded?
Silk Road Medical was founded in 2007.
-
Where is Silk Road Medical headquartered?
Silk Road Medical is headquartered in Sunnyvale, CA.
-
What is the size of Silk Road Medical?
Silk Road Medical has 474 total employees.
-
What industry is Silk Road Medical in?
Silk Road Medical’s primary industry is Therapeutic Devices.
-
Is Silk Road Medical a private or public company?
Silk Road Medical is a Private company.
-
What is the current valuation of Silk Road Medical?
The current valuation of Silk Road Medical is .
-
What is Silk Road Medical’s current revenue?
The current revenue for Silk Road Medical is .
-
How much funding has Silk Road Medical raised over time?
Silk Road Medical has raised $698M.
-
Who are Silk Road Medical’s investors?
CRG, Janus Henderson Investors, Norwest, The Vertical Group, and Warburg Pincus have invested in Silk Road Medical.
-
Who are Silk Road Medical’s competitors?
ShockWave Medical, Penumbra, Spine Wave, Evasc, and Medtronic are some of the 28 competitors of Silk Road Medical.
-
When was Silk Road Medical acquired?
Silk Road Medical was acquired on 17-Sep-2024.
-
Who acquired Silk Road Medical?
Silk Road Medical was acquired by Boston Scientific.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process